Caterpillar Inc vs Heron Therapeutics Inc — how do they compare? Caterpillar Inc trades at $865.02 (market cap $387.68B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Caterpillar Inc is far larger — about 6306.8× Heron Therapeutics Inc's market cap, and Caterpillar Inc pays a 0.77% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| CAT | HRTX | |
|---|---|---|
Market Cap | $387.68B | $61.47M |
Sector | Industrials | Health |
52-Week High | $1.06K | $1.49 |
52-Week Low | $407.79 | $0.32 |
Enterprise Value | $426.11B | $168.21M |
Dividend Yield | 0.77% | — |
Signals from Pluang's Aura AI — not financial advice
Caterpillar (CAT) trades at $837.58, down 0.55% on the day, with a bearish technical signal but strong fundamental performance. Recent quarters have consistently beaten EPS estimates, with Q2 2026 EPS of $8.17 surpassing the $6.22 expectation. Revenue growth is supported by AI data center demand, contributing to a robust $67.59B in 2025 revenue. The stock is near key support at $831, with resistance at $850.
Outlook remains positive due to strong earnings momentum and AI-driven infrastructure demand, though elevated valuation ratios (P/E of 36.32) pose a risk. Analyst consensus is bullish with a $1,010 price target, but investors should monitor macroeconomic pressures and competitive threats. The dividend history and cash flow stability add defensive appeal.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Caterpillar Inc. designs, manufactures, and markets construction, mining, and forestry machinery. The Company also manufactures engines and other related parts for its equipment, and offers financing and insurance. Caterpillar distributes its products through a worldwide organization of dealers.
Read more on CAT →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →